Age, gender, previous history of AMI, HF, HTN, DM, smoking history, territory of infarction, STEMI or NSTEMI, Killip class, eGFR, troponin I, therapy with ACE inhibitors, angiotensin receptor blockers and beta‐blockers, NT‐proBNP, and GDF‐15. This evidence concerns the gene GDF15 and diabetes mellitus.